Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Thoracic 1

Conditions

Pancreatic Neoplasms 21Triple Negative Breast Neoplasms 9Lung Neoplasms 8Neoplasm Metastasis 7Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Head and Neck Neoplasms 3Colorectal Neoplasms 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Gallbladder Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Biliary Tract Neoplasms 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Resectable Pancreatic Cancer 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Non-Small Cell Lung Cancer Metastatic 1Non Small Cell Lung Cancer NSCLC 1Neoplasms, Basal Cell 1

Interventions

pembrolizumab 28Cisplatin 18Cetuximab 12Carboplatin 12Surveys and Questionnaires 9Radiotherapy 9Paclitaxel 8Docetaxel 6Radiotherapy, Intensity-Modulated 5Surgical Procedures, Operative 4Standard of Care 4dostarlimab 3Therapeutics 3Nivolumab 3Fluorouracil 3Cyclophosphamide 3Chemoradiotherapy 3Blood Specimen Collection 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3toripalimab 2nimotuzumab 2fludarabine 2durvalumab 2atezolizumab 2abemaciclib 2X-Rays 2Taxes 2Radiosurgery 2Radiation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Albumin-Bound Paclitaxel × 90 days × Clear all
NCT07601737 2026-05-22

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
182 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT02270814 2026-05-05

CACTUX

Washington University School of Medicine

Phase 2 Active not recruiting
74 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05358548 2026-04-30

ATATcH Alternating Treatment Plans for Advanced Cancer

Rutgers, The State University of New Jersey

Phase 2 Recruiting
150 enrolled
Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡